Davis Polk Reps Charles River In $1.6B WuXi Deal
Medical research service and equipment provider Charles River Laboratories International Inc. said Monday that it would buy China's WuXi PharmaTech (Cayman) Inc. in a $1.6 billion cash-and-stock merger....To view the full article, register now.
Already a subscriber? Click here to view full article